These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 12493338)
1. A widely available method for the assessment of aerosol delivery in cystic fibrosis. Kastelik JA; Wright GA; Aziz I; Davies M; Avery GR; Paddon AJ; Howey S; Morice AH Pulm Pharmacol Ther; 2002; 15(6):513-9. PubMed ID: 12493338 [TBL] [Abstract][Full Text] [Related]
2. Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis. Byrne NM; Keavey PM; Perry JD; Gould FK; Spencer DA Arch Dis Child; 2003 Aug; 88(8):715-8. PubMed ID: 12876172 [TBL] [Abstract][Full Text] [Related]
3. Positive expiratory pressure changes aerosol distribution in patients with cystic fibrosis. Laube BL; Geller DE; Lin TC; Dalby RN; Diener-West M; Zeitlin PL Respir Care; 2005 Nov; 50(11):1438-44. PubMed ID: 16253150 [TBL] [Abstract][Full Text] [Related]
4. [Pulmonary deposition of colistin aerosols in cystic fibrosis. Comparison of an ultrasonic nebulizer and a pneumatic nebulizer]. Gagnadoux F; Diot P; Marchand S; Thompson R; Dieckman K; Lemarié E; Varaigne F; Maurage C; Baulieu JL; Rolland JC Rev Mal Respir; 1996; 13(1):55-60. PubMed ID: 8650418 [TBL] [Abstract][Full Text] [Related]
5. Nebuliser systems for drug delivery in cystic fibrosis. Daniels T; Mills N; Whitaker P Cochrane Database Syst Rev; 2013 Apr; (4):CD007639. PubMed ID: 23633344 [TBL] [Abstract][Full Text] [Related]
6. Lung Deposition of Alpha1-Proteinase Inhibitor (Human) (A1-PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis. Häussermann S; Winnips C; Edelman J; Kappeler D; Herpich C; Ehlich H; Zanker D; Kietzig C; Sommerer K J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):242-50. PubMed ID: 26669827 [TBL] [Abstract][Full Text] [Related]
7. Lung deposition of inhaled tobramycin with eFlow rapid/LC Plus jet nebuliser in healthy and cystic fibrosis subjects. Lenney W; Edenborough F; Kho P; Kovarik JM J Cyst Fibros; 2011 Jan; 10(1):9-14. PubMed ID: 20884302 [TBL] [Abstract][Full Text] [Related]
8. Comparison of breath-enhanced to breath-actuated nebulizers for rate, consistency, and efficiency. Leung K; Louca E; Coates AL Chest; 2004 Nov; 126(5):1619-27. PubMed ID: 15539736 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and tolerability profiles of tobramycin nebuliser solution 300 mg/4 ml administered by PARI eFlow(®) rapid and PARI LC Plus(®) nebulisers in cystic fibrosis patients. Govoni M; Poli G; Acerbi D; Santoro D; Cicirello H; Annoni O; Ružička J Pulm Pharmacol Ther; 2013 Apr; 26(2):249-55. PubMed ID: 23232039 [TBL] [Abstract][Full Text] [Related]
10. Aerosolized protein delivery in asthma: gamma camera analysis of regional deposition and perfusion. Sangwan S; Agosti JM; Bauer LA; Otulana BA; Morishige RJ; Cipolla DC; Blanchard JD; Smaldone GC J Aerosol Med; 2001; 14(2):185-95. PubMed ID: 11681650 [TBL] [Abstract][Full Text] [Related]
11. Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern. Newman SP; Woodman G; Clarke SW Thorax; 1988 Apr; 43(4):318-22. PubMed ID: 3406919 [TBL] [Abstract][Full Text] [Related]
13. Changes in performance of the Pari eFlow rapid and Pari LC Plus during 6 months use by CF patients. Rottier BL; van Erp CJ; Sluyter TS; Heijerman HG; Frijlink HW; Boer AH J Aerosol Med Pulm Drug Deliv; 2009 Sep; 22(3):263-9. PubMed ID: 19466906 [TBL] [Abstract][Full Text] [Related]
14. Accounting for radioactivity before and after nebulization of tobramycin to insure accuracy of quantification of lung deposition. Coates AL; Dinh L; MacNeish CF; Rollin T; Gagnon S; Ho SL; Lands LC J Aerosol Med; 2000; 13(3):169-78. PubMed ID: 11066020 [TBL] [Abstract][Full Text] [Related]
15. Optimization of aerosol deposition by pressure support in children with cystic fibrosis: an experimental and clinical study. Fauroux B; Itti E; Pigeot J; Isabey D; Meignan M; Ferry G; Lofaso F; Willemot JM; Clément A; Harf A Am J Respir Crit Care Med; 2000 Dec; 162(6):2265-71. PubMed ID: 11112150 [TBL] [Abstract][Full Text] [Related]